Peregrine Asset Advisers Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$4.83M |
| 2 |
Xylem
XYL
|
+$4.25M |
| 3 |
Procter & Gamble
PG
|
+$3.43M |
| 4 |
Albemarle
ALB
|
+$3.23M |
| 5 |
Live Nation Entertainment
LYV
|
+$3.12M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$5.92M |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$4.19M |
| 3 |
Amazon
AMZN
|
+$3.77M |
| 4 |
PNC Financial Services
PNC
|
+$3.3M |
| 5 |
PepsiCo
PEP
|
+$2.55M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 24.25% |
| 2 | Consumer Staples | 12.37% |
| 3 | Communication Services | 11.12% |
| 4 | Technology | 10.93% |
| 5 | Consumer Discretionary | 8.25% |
Similar funds
Peregrine Asset Advisers's Q2 2023 Portfolio in Review
As of Q2 2023, Peregrine Asset Advisers held 81 positions worth $130M, up 28% from $102M the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Peregrine Asset Advisers deployed $17.5M of net new capital in Q2 2023, opening 17 new positions and adding to 18 existing holdings. Its largest new stake was Vertex Pharmaceuticals: 14,326 shares worth $5.04M.
By sector, the portfolio is most concentrated in Industrials at 24% of assets, up from 22% a quarter earlier, followed by Consumer Staples and Communication Services.
On the sell side, the largest reduction was Amazon, an estimated $3.77M trimmed.
- Peregrine Asset Advisers's largest Q2 2023 buy was Vertex Pharmaceuticals: 14,326 shares worth $5.04M.
- Peregrine Asset Advisers added most to Xylem in Q2 2023, an estimated $4.25M increase.
- Peregrine Asset Advisers's biggest Q2 2023 reduction was Amazon, cutting an estimated $3.77M.
- Peregrine Asset Advisers fully exited Abbott in Q2 2023, selling an estimated $5.92M.
- Peregrine Asset Advisers's ten largest holdings make up 41% of its $130M portfolio in Q2 2023.
- Peregrine Asset Advisers opened 17 new positions and closed 6 in Q2 2023.
- Peregrine Asset Advisers's portfolio value rose 28% quarter-over-quarter to $130M.
Based on Peregrine Asset Advisers's 13F filing for Q2 2023, filed 7 Aug 2023.